help button home button Am J Pathol R & D Systems
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hattori, A.
Right arrow Articles by Shinozuka, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hattori, A.
Right arrow Articles by Shinozuka, H.

American Journal of Pathology, Vol 128, 111-120, Copyright © 1987 by American Society for Investigative Pathology


REGULAR ARTICLES

Thymic and lymphoid changes and serum immunoglobulin abnormalities in mice receiving cyclosporine

A Hattori, HW Kunz, TJ Gill 3d and H Shinozuka

The authors recently demonstrated that cyclosporine (CsA) enhanced the development of murine thymic lymphomas by its tumor promoter-like action. To clarify the underlying mechanism, they investigated the morphologic alterations in the thymus and other lymphoid tissues and the serum immunoglobulin abnormalities in mice receiving CsA. Feeding male Swiss Webster mice with diets containing 0.015% and 0.027% CsA for 1, 2, 4, and 8 weeks led to a marked reduction of the thymic medulla. Thymocytes remaining after CsA treatment were completely destroyed by a single injection of cortisone acetate (8 mg/mice), and cortisone- resistant cells were markedly decreased. Immunoperoxidase staining using anti-keratin antibodies showed a decrease in the number of keratin-positive cells, presumably epithelial cells, in the thymus of CsA-treated mice. These changes were completely reversible within 4 weeks after withdrawing CsA from the diet. The lymph nodes and the gut- associated lymphoid tissues of CsA-treated mice showed blurring of the germinal centers, diminished Thy-1-positive lymphocytes, and proliferation of lymphocytes carrying IgG, IgM, and IgA on their surface. Similar changes were observed in the spleens of CsA-treated mice. There was a slight increase in serum IgG, a twofold increase in serum IgM, and a six- to tenfold increase in serum IgA. The results suggest that CsA interferes with the functions of both T and B lymphocytes in vivo and that disturbance of T-cell maturation in the thymus may be the mechanism by which CsA promotes the induction of thymic lymphomas in mice.


This article has been cited by other articles:


Home page
BloodHome page
D. V. Kuprash, V. E. Boitchenko, F. O. Yarovinsky, N. R. Rice, A. Nordheim, A. Ruhlmann, and S. A. Nedospasov
Cyclosporin A blocks the expression of lymphotoxin alpha , but not lymphotoxin beta , in human peripheral blood mononuclear cells
Blood, August 13, 2002; 100(5): 1721 - 1727.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Y. Wu and I. Goldschneider
Tolerance to Cyclosporin A-Induced Autologous Graft-Versus-Host Disease Is Mediated by a CD4+CD25+ Subset of Recent Thymic Emigrants
J. Immunol., June 15, 2001; 166(12): 7158 - 7164.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Y. Wu and I. Goldschneider
Cyclosporin A-Induced Autologous Graft-Versus-Host Disease: A Prototypical Model of Autoimmunity and Active (Dominant) Tolerance Coordinately Induced by Recent Thymic Emigrants
J. Immunol., June 1, 1999; 162(11): 6926 - 6933.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1987 by the American Society for Investigative Pathology.